Skip to main content
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Special Series
Conference Correspondent
AMCP Nexus 2022
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Special Series
Conference Correspondent
AMCP Nexus 2022
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Unmet Needs in Patients with Myeloma
Hematologic Cancers
,
Conference Correspondent
,
ASH Highlights
Conference Correspondent
Beth Faiman, PhD, APRN-BC, AOCN
Founding Editor in Chief
Patients with newly diagnosed multiple myeloma have different needs than pateints relapsed/refractory disease, and Beth Faiman addresses what some of these needs are.
Related Items
Polatuzumab Vedotin plus R-CHP Outperforms Standard of Care in Treatment of DLBCL
TOP - March 2022 Vol 15, No 2
ASH Highlights
,
Lymphoma
Time-Limited Venetoclax-Based Regimens Demonstrate Promising Efficacy in Fit Patients with CLL
TOP - March 2022 Vol 15, No 2
ASH Highlights
Mosunetuzumab Induces Deep Remissions in Patients with Relapsed/Refractory Follicular Lymphoma
By
William King
TOP - January 2022 Vol 15, No 1 – Online Only
ASH Highlights
Results from 2 Studies Provide Insights on Antibody Response to COVID-19 Vaccines in Patients with Hematologic Malignancies
By
William King
TOP - January 2022 Vol 15, No 1 – Online Only
ASH Highlights